article · Open Forum Infectious Diseases

High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May–October 2021) in Matadi, Democratic Republic of the Congo

Yannick Munyeku-Bazitama
Ryoko Asari
Mitsuo Isono
Jacques Kimfuta
Marc K Yambayamba
Paul M Tshiminyi
Lionel K Baketana
Saeda Makimoto
Sheila Makiala‐Mandanda
Patrick I. Mpingabo
Goethe Makindu
Steve Ahuka‐Mundeke
Patient Okitale-Talunda
Raymond Mufwaya-Nsene
Aimé Umba-Phuati
Justus Nsio-Mbeta
Ferdinand A Phukuta
Jean‐Jacques Muyembé‐Tamfum

20236 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

The SARS-CoV-2 seroprevalence was very high, contrasting with reported cases. Evidence generated from this population-based survey remains relevant in guiding the local COVID-19 response, especially vaccination strategies.

Research topics

SARS-CoV-2 and COVID-19 Research
COVID-19 epidemiological studies
COVID-19 Clinical Research Studies

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1093/ofid/ofad023

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.